| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SELECTA BIOSCIENCES INC | 1,924,151 | 27,419,000 | 28.95% | ||
| 2 | TREVENA INC | 2,053,540 | 13,861,000 | 14.63% | ||
| 3 | T2 BIOSYSTEMS INC | 1,875,524 | 13,579,000 | 14.34% | ||
| 4 | GENOCEA BIOSCIENCES INC | 1,968,606 | 10,079,000 | 10.64% | ||
| 5 | FATE THERAPEUTICS INC COM | 2,473,186 | 7,716,000 | 8.15% | ||
| 6 | OCULAR THERAPEUTIX INC | 998,713 | 6,861,000 | 7.24% | ||
| 7 | PULMATRIX INC | 3,607,996 | 5,953,000 | 6.28% | ||
| 8 | Life Technologies Corp | 1,827,992 | 5,813,000 | 6.14% | ||
| 9 | CERULEAN PHARMA INC | 3,287,529 | 3,442,000 | 3.63% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021526, filed 2016.11.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
